Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein - Rationale and design of the JUPITER trial

被引：332

作者：

Ridker, PM ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA

来源：

CIRCULATION | 2003年 / 108卷 / 19期

关键词：

D O I：

10.1161/01.CIR.0000100688.17280.E6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2292 / 2297

页数：6

共 57 条

[1] Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death [J].

Albert, CM ;

Ma, J ;

Rifai, N ;

Stampfer, MJ ;

Ridker, PM .

CIRCULATION, 2002, 105 (22) :2595-2599

[2] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].

Albert, MA ;

Danielson, E ;

Rifai, N ;

Ridker, PM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70

[3] Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia - A prospective, randomized, double-blind trial [J].

Ballantyne, CM ;

Houri, J ;

Notarbartolo, A ;

Melani, L ;

Lipka, LJ ;

Suresh, R ;

Sun, S ;

LeBeaut, AP ;

Sager, PT ;

Veltri, EP .

CIRCULATION, 2003, 107 (19) :2409-2415

[4] Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease [J].

Bickel, C ;

Rupprecht, HJ ;

Blankenberg, S ;

Espiniola-Klein, C ;

Schlitt, A ;

Rippin, G ;

Hafner, G ;

Treude, R ;

Othman, H ;

Hofmann, KP ;

Meyer, J .

AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (08) :901-908

[5] Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty [J].

Buffon, A ;

Liuzzo, G ;

Biasucci, LM ;

Pasqualetti, P ;

Ramazzotti, V ;

Rebuzzi, AG ;

Crea, F ;

Maseri, A .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (05) :1512-1521

[6] HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis [J].

Bustos, C ;

Hernández-Presa, MA ;

Ortego, M ;

Tuñón, J ;

Ortega, L ;

Pérez, F ;

Díaz, C ;

Hernández, G ;

Egido, J .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) :2057-2064

[7] Relation of inflammation and benefit of statins after percutaneous coronary interventions [J].

Chan, AW ;

Bhatt, DL ;

Chew, DP ;

Reginelli, J ;

Schneider, JP ;

Topol, EJ ;

Ellis, SG .

CIRCULATION, 2003, 107 (13) :1750-1756

[8] Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women [J].

Chan, KA ;

Andrade, SE ;

Boles, M ;

Buist, DSM ;

Chase, GA ;

Donahue, JG ;

Goodman, MJ ;

Gurwitz, JH ;

LaCroix, AZ ;

Platt, R .

LANCET, 2000, 355 (9222) :2185-2188

[9] Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention [J].

Chew, DP ;

Bhatt, DL ;

Robbins, MA ;

Penn, MS ;

Schneider, JP ;

Lauer, MS ;

Topol, EJ ;

Ellis, SG .

CIRCULATION, 2001, 104 (09) :992-997

[10] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

← 1 2 3 4 5 6 →